No ASX ETF holds Mayne Pharma (MYX) as of 15 Oct 2026. Over the last 3 months it fell 11.7%: on $10,000, −$1170. We explain 2 big moves in that time.
About MYX
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$208.0m
- Held by0 ETFs
- Big moves2 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- −5.7%10 Sep 2026· No Catalyst Found
MYX fell alongside a broad healthcare sector sell-off, with the ASX health index down 2.3% and 36 industry peers down a median 2.3% on the same day.
- +10.2%peak +11.3%3 Aug 2026· Sector Flow
MYX.AX rose sharply alongside a broad rally in the ASX healthcare sector, which gained over 2.3% on the same day, lifting sentiment across health-related stocks.
Held by 0 ETFs
No ETF we track holds MYX directly.
Other Health Care companies
- SHLSonic Healthcare47 ETFs
- RMDResMed44 ETFs
- CSLCSL Limited42 ETFs
- BDXBcal36 ETFs
- CSXCleanspace36 ETFs
- REGRegis Health33 ETFs
- TLXTelix Pharma32 ETFs
- SIGSigma Healthcare31 ETFs
Why did MYX rise 10.2% on 3 Aug 2026?
Mayne Pharma
MYX.AX rose sharply alongside a broad rally in the ASX healthcare sector, which gained over 2.3% on the same day, lifting sentiment across health-related stocks.
There are no company-specific announcements or news articles to explain the move, leaving sector momentum as the primary candidate. The ASX Health index (^AXHJ) moved up 2.36% on the same day, which directionally matches and is above its normal threshold, providing a plausible sector-driven tailwind. However, MYX's move at 8.83% and 4x its normal daily range is significantly larger than the sector gain, suggesting either amplified beta sensitivity to the sector move or a residual unknown catalyst not captured in the available data, which tempers confidence.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
Sector / macro signals